Two Sigma Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.91M | Sell |
18,000
-12,800
| -42% | -$2.84M | ﹤0.01% | 2193 |
|
|
2025
Q4 | $7.04M | Buy |
30,800
+19,700
| +177% | +$4.49M | 0.01% | 1400 |
|
|
2025
Q3 | $2.57M | Buy |
+11,100
| New | +$2.26M | ﹤0.01% | 1958 |
|
|
2022
Q1 | – | Sell |
-43,900
| Closed | -$5.94M | – | 2551 |
|
|
2021
Q4 | $5.94M | Sell |
43,900
-22,800
| -34% | -$2.69M | 0.01% | 1093 |
|
|
2021
Q3 | $7.2M | Sell |
66,700
-67,400
| -50% | -$7.7M | 0.02% | 965 |
|
|
2021
Q2 | $15.1M | Buy |
134,100
+66,800
| +99% | +$7.52M | 0.03% | 612 |
|
|
2021
Q1 | $7.28M | Sell |
67,300
-19,300
| -22% | -$2.06M | 0.02% | 852 |
|
|
2020
Q4 | $9.28M | Sell |
86,600
-47,100
| -35% | -$4.53M | 0.03% | 627 |
|
|
2020
Q3 | $11.7M | Buy |
133,700
+99,500
| +291% | +$9.37M | 0.04% | 456 |
|
|
2020
Q2 | $3.36M | Sell |
34,200
-34,400
| -50% | -$3.03M | 0.02% | 838 |
|
|
2020
Q1 | $5.23M | Sell |
68,600
-221,400
| -76% | -$18.9M | 0.04% | 480 |
|
|
2019
Q4 | $25.7M | Buy |
290,000
+46,900
| +19% | +$3.89M | 0.08% | 298 |
|
|
2019
Q3 | $18.4M | Buy |
243,100
+130,100
| +115% | +$8.92M | 0.06% | 368 |
|
|
2019
Q2 | $8.22M | Buy |
113,000
+63,700
| +129% | +$5.01M | 0.03% | 676 |
|
|
2019
Q1 | $3.97M | Sell |
49,300
-27,700
| -36% | -$2.27M | 0.01% | 1076 |
|
|
2018
Q4 | $7.1M | Buy |
77,000
+20,500
| +36% | +$1.8M | 0.03% | 651 |
|
|
2018
Q3 | $5.34M | Sell |
56,500
-52,300
| -48% | -$4.96M | 0.01% | 919 |
|
|
2018
Q2 | $10.1M | Buy |
108,800
+75,500
| +227% | +$7.37M | 0.03% | 668 |
|
|
2018
Q1 | $3.15M | Sell |
33,300
-108,500
| -77% | -$11.9M | 0.01% | 1213 |
|
|
2017
Q4 | $13.7M | Buy |
141,800
+126,500
| +827% | +$11.9M | 0.04% | 484 |
|
|
2017
Q3 | $1.36M | Sell |
15,300
-62,600
| -80% | -$4.77M | ﹤0.01% | 1535 |
|
|
2017
Q2 | $5.65M | Buy |
77,900
+35,800
| +85% | +$2.41M | 0.02% | 793 |
|
|
2017
Q1 | $2.74M | Sell |
42,100
-120,200
| -74% | -$7.56M | 0.01% | 1259 |
|
|
2016
Q4 | $10.2M | Sell |
162,300
-36,600
| -18% | -$2.23M | 0.04% | 529 |
|
|
2016
Q3 | $12.5M | Buy |
198,900
+128,900
| +184% | +$8.34M | 0.05% | 459 |
|
|
2016
Q2 | $4.33M | Sell |
70,000
-43,000
| -38% | -$2.62M | 0.02% | 836 |
|
|
2016
Q1 | $6.46M | Buy |
113,000
+13,000
| +13% | +$725K | 0.03% | 612 |
|
|
2015
Q4 | $5.92M | Buy |
+100,000
| New | +$5.76M | 0.03% | 611 |
|
|
2015
Q3 | – | Sell |
-63,000
| Closed | -$4.23M | – | 2124 |
|
|
2015
Q2 | $4.23M | Buy |
63,000
+40,000
| +174% | +$2.61M | 0.02% | 796 |
|
|
2015
Q1 | $1.35M | Buy |
+23,000
| New | +$1.39M | 0.01% | 1396 |
|
Other funds holding ABBV
VCM
VPM
Two Sigma Investments's ABBV Position: Q1 2026 in Review
Two Sigma Investments increased its AbbVie (ABBV) stake by 56% in Q1 2026, buying an estimated $14.1M and bringing the position to 178,418 shares worth $38.8M. The position accounts for 0.03% of the portfolio, ranked #607.
Two Sigma Investments first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $261M in Q4 2021. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Two Sigma Investments held 178,418 shares of AbbVie worth $38.8M as of Q1 2026.
- Two Sigma Investments bought 63,706 AbbVie shares in Q1 2026, an estimated $14.1M.
- AbbVie made up 0.03% of Two Sigma Investments's portfolio in Q1 2026, its #607 holding.
- Two Sigma Investments first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Two Sigma Investments's AbbVie position peaked at $261M in Q4 2021.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.